George A. Kaysen
Professor of Medicine and Biochemistry and Molecular Medicine
gakaysen@ucdavis.edu

Nephrology (Internal Med)
Biological Chemistry -Medicine

Office
GBSF 451 East Health Sciences Drive
530 752-2970


Picture of George A. Kaysen
 
Degrees:
1975 Albert Einstein School of Medicine 1975-1977, Fellow
1973 Albert Einstein College of Medicine 1973-75 Resident
1972 MD Albert Einstein College of Medicine
1972 PhD Albert Einstein College of Medicine Biochemistry
1972 Albert Einstein College of Medicine 1972-73 Intern
1965 BS Franklin and Marshall College, Pennsylvania Chemistry
Research Interests:

Mechanism of hyperlipidemia in renal disease, consequence and cause of inflammation in dialysis, effects of inflammation on vascular endothelial structure and function, regulation of plasma protein composition
Department and Center Affiliations:
Department of Veterans Affairs Medical Center
Department of Medicine
Professional Societies:
American Society of Nephrology
International Society of Nephrology
International Society of Renal Nutrition and Metabolism (President)
National Kidney Foundation
CBS Graduate Group Affiliations:
Molecular, Cellular, and Integrative Physiology  
Publications:
  • 2003 Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales L, Levin NW. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney International 63(1):315-322.
  • 2002 Prinsen BH, Kaysen GA, Klomp LW, de Boer J, Barrett PH, Thornalley PJ, Battah S, Berger R, Rabelink TJ, der Velden MG. Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate. Clin Biochem. 35(7):545-53.
  • 2002 Rahmati, M.A., Craig, R.G., Homel, P., Kaysen, G.A., Levin, N.W. Serum markers of periodontal disease status and inflammation in hemodialysis patients. American Journal of Kidney Diseases. 40(5): 983-89.
  • 2002 Beddhu, S., Kaysen, G.A., Yan, G., Sarnak, M., Agodoa, L., Ornt, D., Cheung, A.K. Association of serum albumin and atheroschlerosis in chronic hemodialysis patients. American Journal of Kidney Diseases. 40(4): 721-27.
  • 2002 Kaysen, G.A., Levin, N.W. Why measure serum albumin levels? Journal of Renal Nutrition. 12(3): 148-50.
  • 2002 Kaysen, G.A., Dubin, J.A., Muller, H.G., Mitch, W.E., Rosales, L.M., Levin, N.W. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney International. 61(6): 2240-49.
  • 2002 Kaysen, G.A. Role of inflammation and its treatment in ESRD patients. Blood Purification. 20(1): 70-80.
  • 2001 Kaysen, G.A., Dubin, J.A., Muller, H.G., Mitch,W.E., Levin, N.W. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney International. 60(6): 2360-66.
Laboratory Personnel:
Greg Shearer, Davis Campus



Tjien Thio, Davis Campus